tiprankstipranks
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
US Market

Pasithea Therapeutics Corp (KTTA) Financial Statements

28 Followers

Pasithea Therapeutics Corp Financial Overview

Pasithea Therapeutics Corp's market cap is currently ―. The company's EPS TTM is $-12.396; its P/E ratio is -0.59; Pasithea Therapeutics Corp is scheduled to report earnings on March 30, 2022, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ 240.71K$ 218.61K
Gross Profit---$ 242.02K$ 132.14K
EBIT$ -3.61M$ -3.72M$ -3.26M$ -5.12M$ -4.25M
EBITDA$ -3.45M$ -3.55M$ -3.10M$ -5.12M$ -4.23M
Net Income Common Stockholders$ -3.61M$ -3.76M$ 3.16M$ -5.12M$ -4.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.70M$ 26.77M$ 29.91M$ 33.15M$ 42.40M
Total Assets$ 30.66M$ 38.15M$ 41.87M$ 45.18M$ 49.61M
Total Debt$ 385.29K$ 559.10K$ 729.56K$ 926.89K$ 982.42K
Net Debt$ -19.31M$ -26.21M$ -29.18M$ -32.22M$ -41.42M
Total Liabilities$ 2.28M$ 2.56M$ 2.91M$ 2.68M$ 2.82M
Stockholders Equity$ 28.37M$ 35.59M$ 39.14M$ 42.50M$ 46.79M
Cash Flow-
Free Cash Flow$ -2.60M$ -3.47M$ -3.42M$ -6.21M$ -5.44M
Operating Cash Flow$ -2.65M$ -3.50M$ -3.37M$ -4.42M$ -5.24M
Investing Cash Flow$ -273.65K$ 344.01K$ -49.70K$ -1.76M$ -230.43K
Financing Cash Flow$ -3.86M$ -130.77K$ 264.10K$ -3.21M$ 0.00
Currency in USD

Pasithea Therapeutics Corp Earnings and Revenue History

Pasithea Therapeutics Corp Debt to Assets

Pasithea Therapeutics Corp Cash Flow

Pasithea Therapeutics Corp Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis